H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)

Go back to H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)
(NYSE: LCTX) Delayed: 1.08 --0 (-0%)
Previous Close $1.08    52 Week High
Open $1.08    52 Week Low
Day High $1.08    P/E N/A 
Day Low $1.08    EPS
Volume 67